Author:
Keegan Theresa H. M.,Gopalakrishnan Geetha,Sidney Stephen,Quesenberry Charles P.,Kelsey Jennifer L.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference23 articles.
1. Cauley JA, Salamone LM (2001) Postmenopausal endogenous and exogenous hormones, degree of obesity, thiazide diuretics, and risk of osteoporosis. In: Marcus R, Feldman D, Kelsey JL (eds) Osteoporosis, 2nd edn, Vol 1. Academic Press, San Diego, pp 741–769
2. Mosekilde L, Beck-Nielsen H, Sorensen OH, Nielsen SP, Charles P, Vestergaard P, Hermann AP, Gram J, Hansen TB, Abrahamsen B, Ebbesen EN, Stilgren L, Jensen LB, Brot C, Hansen B, Tofteng CL, Eiken P, Kolthoff N (2000) Hormone replacement therapy reduces forearm fracture incidence in recent postmenopausal women—results of the Danish Osteoporosis Prevention Study. Maturitas 36:181–193
3. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the Women's Health Initiative randomized controlled trial. JAMA 288:321–333
4. Torgerson DJ, Bell-Syer SEM (2001) Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 285:2891–2897
5. Hully S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W et al (2002) Noncardiovascular disease outcomes during 6.8 years of hormone therapy: the Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288:58–66
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献